German drugmaker Merck KGaA has begun the second year of its five-year project to provide diabetes management courses for medical and pharmacy students in African Universities.
German drugmaker Merck KGaA has begun the second year of its five-year project to provide diabetes management courses for medical and pharmacy students in African Universities.
The Merck Capacity Advancement Program (CAP) will be provided at the Universities of Nairobi, Makerere, Uganda, and Namibia, before moving to Tanzania and Ghana. Merck is also offering every healthcare provider in those countries and the rest of Africa free access to the lectures via e-learning at www.managediabetesonline.org.
This year the company aims to reach 2,000 students and rural healthcare providers, who will have the opportunity to become “diabetes ambassadors” across Africa.
Merck’s Dr. Stefan Oschmann and Professor Sidat Mohsin, dean of the medical school at Eduardo Mondelane University, Mozambique.
The challenges faced by African countries in tackling diabetes are well known: services for the care of chronic diseases are poorly organized; public awareness about diabetes is limited, and well-structured education programs for patients and health professionals are unavailable.
According to the International Diabetes Federation, the number of people with diabetes in Africa could double by 2035. The proportion of deaths due to diabetes in people under 60 years in Africa is currently 76%, and 46% of people living with diabetes are still undiagnosed.
Next year Merck’s program will be extended to more universities across Africa such as Nigeria and Ethiopia, and to Asian countries such as Indonesia and India.
The Weight-Loss Gold Rush: Legal and Regulatory Implications
July 11th 2024Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses how the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs, what needs to be done for GLP-1s to be covered, advice for investors and financiers considering entering the weight-loss medication market and more.
Healthcare Marketing Strategies for Reaching Diverse Audiences
May 14th 2024Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more.